The Shotlee Journal
Browse Shotlee articles about Mounjaro.
Showing 9 / 799 Mounjaro articles
A recent study indicates that GLP-1 receptor agonists and incretin-based drugs may decrease mortality risk and hospital visits for adults with type 1 diabetes. Researchers compared outcomes in users versus non-users, finding significant benefits across BMI categories. Further long-term studies are needed to confirm safety and efficacy.
With slimming injections gaining immense popularity, curiosity rises about a potential natural substitute known as 'natural Ozempic,' a supplement aimed at boosting hormones to curb appetite. While it draws from oils to mimic effects similar to GLP-1, scientists debate its maturity and real-world impact. This piece delves into the supporting evidence, expert critiques, and comparisons with established medications.
Former 'Dancing With the Stars' troupe member Stephani Sosa openly discusses her use of Ozempic during the show and her ongoing health journey. She also shares details about liposuction and maintaining a fit lifestyle post-procedure. As she moves away from the series, Sosa focuses on new acting opportunities and personal growth.
Before starting Ozempic in spring 2023, Brenda Rogers hadn't recognized how 'food noise' drained her mental stamina. This term describes a constant preoccupation with food, tied to GLP-1 medications for diabetes and obesity. Experts explain its causes, how drugs alleviate it, and alternative approaches like therapy and diet adjustments.
Thousands are resuming their weight-loss drugs after holiday pauses, but experts caution about heightened side effects. Research indicates many users wait until New Year to restart regimens. Follow guidelines to avoid rebound issues and manage doses safely.
Senior citizens in the U.S. often discontinue highly effective weight-loss medications such as GLP-1 drugs shortly after starting them, resulting in regained pounds and diminished health advantages. Side effects, high expenses, and inadequate insurance coverage frequently play key roles in this trend. Experts advocate for better coverage and ongoing research to address these challenges for older populations.
A University of Oxford study indicates that weight loss from medications like GLP-1 drugs often rebounds quickly upon cessation, faster than after dieting and exercise. Behavioral programs lead to slower regain, emphasizing sustainable lifestyle changes. Obesity impacts billions globally, raising risks for heart disease and diabetes.
The introduction of a GLP-1 pill for weight loss marks a significant advancement in obesity treatment, offering an oral alternative to injections like Wegovy. Experts highlight its potential for broader access, though it shares similar expenses, adverse effects, and the necessity for a healthy lifestyle. Key details cover efficacy, timelines for results, pricing, side effects, dosing requirements, and upcoming options.
As January approaches, numerous individuals set New Year's resolutions focused on health and weight reduction goals. While exercise, gym visits, and nutritious diets support well-being and weight management, some may require additional help from medications. The NHS offers an important warning for those using Mounjaro injections alongside contraception or HRT.
